Stay updated on ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Sign up to get notified when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.

Latest updates to the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page
- Check3 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing Revision: v3.5.0. This update reflects a backend/UI version change and does not affect the study details shown.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.0 was added to the site changelog, and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed. This update does not alter study details or page content.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision: v3.4.2 was added; prior notices including v3.4.1 and the government funding lapse notice were removed.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a site-wide funding/status notice indicating the NIH Clinical Center is open and where to find operating status updates. Updated the page version to v3.4.1, replacing the previous v3.4.0 reference.SummaryDifference0.4%

- Check81 days agoChange DetectedMinor wording and label updates were made across the page, including a new 'Show glossary' UI label and capitalization tweaks (e.g., 'QC Criteria' and 'FEAR Act data'). The revision tag was updated to v3.4.0, replacing the prior v3.3.4, and related metadata phrasing was adjusted accordingly.SummaryDifference0.2%

Stay in the know with updates to ADVM-022 Gene Therapy for Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVM-022 Gene Therapy for Wet AMD Clinical Trial page.